NYBC Ventures
North America, Massachusetts, United States, Boston
Description
NYBC Ventures to accelerate innovation in blood-related fields and cellular therapies.
Investor Profile
NYBC Ventures has made 13 investments, with 2 in the past 12 months and 46% as lead.
Stage Focus
- Seed (46%)
- Series Unknown (31%)
- Series C (8%)
- Series A (8%)
- Series B (8%)
Country Focus
- United States (92%)
- The Netherlands (8%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Bioinformatics
- Test And Measurement
- Pharmaceutical
- Life Science
- Emergency Medicine
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.